CD31 Antibody Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • cd31  (Abcam)
    99
    Abcam cd31
    Cd31, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd31/product/Abcam
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    cd31 - by Bioz Stars, 2021-05
    99/100 stars
      Buy from Supplier

    99
    Abcam anti cd31 antibodies
    Angiogenesis regulated by cell bricks prevented central necrosis. Evaluation of angiogenesis in PDCM-CB-P constructs at week 4. ( A , C ) Histological images of infiltration of the capillaries at week 4, bar = 200 m, magnification = 20×. ( B , D ) <t>CD31</t> immunofluorescent staining, bar = 200 μm, magnification = 20×. ( E ) Comparison of the number of blood vessels between the PDCM-CB-P and PDCM-P groups. The valueS represent the cumulative number of all slides examined (n = 6). * P
    Anti Cd31 Antibodies, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd31 antibodies/product/Abcam
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti cd31 antibodies - by Bioz Stars, 2021-05
    99/100 stars
      Buy from Supplier

    86
    Agilent technologies cd31
    Periodontally healthy patients: no RANKL expression in either tissue compartment of the biopsy; no <t>CD31</t> activity detectable (same sample; 20× for both)
    Cd31, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd31/product/Agilent technologies
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    cd31 - by Bioz Stars, 2021-05
    86/100 stars
      Buy from Supplier


    N/A
    CD31 also called PECAM 1 is a transmembrane glycoprotein member of the immunoglobulin supergene family of adhesion molecules It is expressed by stem cells of the hematopoietic system and CD31
      Buy from Supplier

    N/A
    CD31 is a cell adhesion molecule expressed on platelets and at endothelial cell intercellular junctions
      Buy from Supplier

    N/A
    CD31 Antibody is a Rabbit Polyclonal antibody against CD31 The protein encoded by this gene is found on the surface of platelets monocytes neutrophils and some types of T cells
      Buy from Supplier

    Image Search Results


    Angiogenesis regulated by cell bricks prevented central necrosis. Evaluation of angiogenesis in PDCM-CB-P constructs at week 4. ( A , C ) Histological images of infiltration of the capillaries at week 4, bar = 200 m, magnification = 20×. ( B , D ) CD31 immunofluorescent staining, bar = 200 μm, magnification = 20×. ( E ) Comparison of the number of blood vessels between the PDCM-CB-P and PDCM-P groups. The valueS represent the cumulative number of all slides examined (n = 6). * P

    Journal: Scientific Reports

    Article Title: Injectable cartilaginous template transformed BMSCs into vascularized bone

    doi: 10.1038/s41598-018-26472-8

    Figure Lengend Snippet: Angiogenesis regulated by cell bricks prevented central necrosis. Evaluation of angiogenesis in PDCM-CB-P constructs at week 4. ( A , C ) Histological images of infiltration of the capillaries at week 4, bar = 200 m, magnification = 20×. ( B , D ) CD31 immunofluorescent staining, bar = 200 μm, magnification = 20×. ( E ) Comparison of the number of blood vessels between the PDCM-CB-P and PDCM-P groups. The valueS represent the cumulative number of all slides examined (n = 6). * P

    Article Snippet: The samples were then incubated with primary anti-CD31 antibodies (mouse anti-rabbit, 1:100; Abcam) was incubated at 4 °C overnight, followed by Cy3-AffiniPure conjugated secondary antibodies (goat anti-mouse, 1:100; Jackson America).

    Techniques: Construct, Staining

    APR-246 and 2aG4 combination treatment reduces angiogenesis markers in breast tumor xenografts in nude mice. Notes: At the termination of the experiments tumor tissue sections were immunostained for (A) VEGF and (B) CD31 and the signal was quantified. Left, representative images of immunostaining. Right, bar graph represents quantitated (A) VEGF signal or (B) blood vessel density shown as the mean±SEM. CD31 staining was used to count the blood vessels and determine blood vessel density. Inserts represent negative controls. *Significantly different from the control group; **significantly different from the control, 2aG4, and APR-246 groups ( P

    Journal: Breast Cancer : Targets and Therapy

    Article Title: A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts

    doi: 10.2147/BCTT.S156285

    Figure Lengend Snippet: APR-246 and 2aG4 combination treatment reduces angiogenesis markers in breast tumor xenografts in nude mice. Notes: At the termination of the experiments tumor tissue sections were immunostained for (A) VEGF and (B) CD31 and the signal was quantified. Left, representative images of immunostaining. Right, bar graph represents quantitated (A) VEGF signal or (B) blood vessel density shown as the mean±SEM. CD31 staining was used to count the blood vessels and determine blood vessel density. Inserts represent negative controls. *Significantly different from the control group; **significantly different from the control, 2aG4, and APR-246 groups ( P

    Article Snippet: Sections were treated with the following primary antibodies for 60 minutes at RT: anti-VEGF antibody (1:100 dilution of a rabbit anti-VEGF polyclonal antibody [sc-152; Santa Cruz Biotechnology]); anti-CD31 (1:100 dilution of a rabbit anti-CD31 polyclonal antibody [Ab28364; Abcam, Cambridge, MA, USA]); or anti-Ki67 (1:300 dilution of a rabbit anti-Ki67 polyclonal antibody [RB1510-P; Thermo Fisher Scientific]).

    Techniques: Mouse Assay, Immunostaining, Staining

    Periodontally healthy patients: no RANKL expression in either tissue compartment of the biopsy; no CD31 activity detectable (same sample; 20× for both)

    Journal: Central-European Journal of Immunology

    Article Title: Receptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery

    doi: 10.5114/ceji.2014.47737

    Figure Lengend Snippet: Periodontally healthy patients: no RANKL expression in either tissue compartment of the biopsy; no CD31 activity detectable (same sample; 20× for both)

    Article Snippet: Staining was done with primary mouse anti-human monoclonal antibodies specific for CD31 (DaKoCytomation, Glostrup, Denmark), and RANKL (Clone 2C3A 12 C, BioVendor GmbH, Heidelberg, Germany).

    Techniques: Expressing, Activity Assay

    CD31 staining shows capillary walls with active cells in the connective tissue compartment of the core biopsy (100×, respectively)

    Journal: Central-European Journal of Immunology

    Article Title: Receptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery

    doi: 10.5114/ceji.2014.47737

    Figure Lengend Snippet: CD31 staining shows capillary walls with active cells in the connective tissue compartment of the core biopsy (100×, respectively)

    Article Snippet: Staining was done with primary mouse anti-human monoclonal antibodies specific for CD31 (DaKoCytomation, Glostrup, Denmark), and RANKL (Clone 2C3A 12 C, BioVendor GmbH, Heidelberg, Germany).

    Techniques: Staining

    Patient 4 (periodontitis group): strong RANKL expression in various cell types (64×) (Tbl. 1) associated with strong CD31 activity (44×) in connective tissues

    Journal: Central-European Journal of Immunology

    Article Title: Receptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery

    doi: 10.5114/ceji.2014.47737

    Figure Lengend Snippet: Patient 4 (periodontitis group): strong RANKL expression in various cell types (64×) (Tbl. 1) associated with strong CD31 activity (44×) in connective tissues

    Article Snippet: Staining was done with primary mouse anti-human monoclonal antibodies specific for CD31 (DaKoCytomation, Glostrup, Denmark), and RANKL (Clone 2C3A 12 C, BioVendor GmbH, Heidelberg, Germany).

    Techniques: Expressing, Activity Assay

    Negative controls (connective tissue from palatal aspect of the flap) no RANKL expression (20×) and no CD31 (5×) activity detectable

    Journal: Central-European Journal of Immunology

    Article Title: Receptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery

    doi: 10.5114/ceji.2014.47737

    Figure Lengend Snippet: Negative controls (connective tissue from palatal aspect of the flap) no RANKL expression (20×) and no CD31 (5×) activity detectable

    Article Snippet: Staining was done with primary mouse anti-human monoclonal antibodies specific for CD31 (DaKoCytomation, Glostrup, Denmark), and RANKL (Clone 2C3A 12 C, BioVendor GmbH, Heidelberg, Germany).

    Techniques: Expressing, Activity Assay

    Negative controls (connective tissue from palatal aspect of the flap) no RANKL expression (20×) and no CD31 (5×) activity detectable

    Journal: Central-European Journal of Immunology

    Article Title: Receptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery

    doi: 10.5114/ceji.2014.47737

    Figure Lengend Snippet: Negative controls (connective tissue from palatal aspect of the flap) no RANKL expression (20×) and no CD31 (5×) activity detectable

    Article Snippet: Staining was done with primary mouse anti-human monoclonal antibodies specific for CD31 (DaKoCytomation, Glostrup, Denmark), and RANKL (Clone 2C3A 12 C, BioVendor GmbH, Heidelberg, Germany).

    Techniques: Expressing, Activity Assay

    CD31 staining shows capillary walls with active cells in the connective tissue compartment of the core biopsy (100×, respectively)

    Journal: Central-European Journal of Immunology

    Article Title: Receptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery

    doi: 10.5114/ceji.2014.47737

    Figure Lengend Snippet: CD31 staining shows capillary walls with active cells in the connective tissue compartment of the core biopsy (100×, respectively)

    Article Snippet: Staining was done with primary mouse anti-human monoclonal antibodies specific for CD31 (DaKoCytomation, Glostrup, Denmark), and RANKL (Clone 2C3A 12 C, BioVendor GmbH, Heidelberg, Germany).

    Techniques: Staining

    Patient 16 in the chronic periodontitis group; biopsy harvesting at surgery: strong RANKL reaction (110×) combined with weak CD31 staining (44×)

    Journal: Central-European Journal of Immunology

    Article Title: Receptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery

    doi: 10.5114/ceji.2014.47737

    Figure Lengend Snippet: Patient 16 in the chronic periodontitis group; biopsy harvesting at surgery: strong RANKL reaction (110×) combined with weak CD31 staining (44×)

    Article Snippet: Staining was done with primary mouse anti-human monoclonal antibodies specific for CD31 (DaKoCytomation, Glostrup, Denmark), and RANKL (Clone 2C3A 12 C, BioVendor GmbH, Heidelberg, Germany).

    Techniques: Staining

    Patient 16 in the chronic periodontitis group; biopsy harvesting at surgery: strong RANKL reaction (110×) combined with weak CD31 staining (44×)

    Journal: Central-European Journal of Immunology

    Article Title: Receptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery

    doi: 10.5114/ceji.2014.47737

    Figure Lengend Snippet: Patient 16 in the chronic periodontitis group; biopsy harvesting at surgery: strong RANKL reaction (110×) combined with weak CD31 staining (44×)

    Article Snippet: Staining was done with primary mouse anti-human monoclonal antibodies specific for CD31 (DaKoCytomation, Glostrup, Denmark), and RANKL (Clone 2C3A 12 C, BioVendor GmbH, Heidelberg, Germany).

    Techniques: Staining

    Periodontally healthy patients: no RANKL expression in either tissue compartment of the biopsy; no CD31 activity detectable (same sample; 20× for both)

    Journal: Central-European Journal of Immunology

    Article Title: Receptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery

    doi: 10.5114/ceji.2014.47737

    Figure Lengend Snippet: Periodontally healthy patients: no RANKL expression in either tissue compartment of the biopsy; no CD31 activity detectable (same sample; 20× for both)

    Article Snippet: Staining was done with primary mouse anti-human monoclonal antibodies specific for CD31 (DaKoCytomation, Glostrup, Denmark), and RANKL (Clone 2C3A 12 C, BioVendor GmbH, Heidelberg, Germany).

    Techniques: Expressing, Activity Assay

    Patient 4 (periodontitis group): strong RANKL expression in various cell types (64×) (Tbl. 1) associated with strong CD31 activity (44×) in connective tissues

    Journal: Central-European Journal of Immunology

    Article Title: Receptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery

    doi: 10.5114/ceji.2014.47737

    Figure Lengend Snippet: Patient 4 (periodontitis group): strong RANKL expression in various cell types (64×) (Tbl. 1) associated with strong CD31 activity (44×) in connective tissues

    Article Snippet: Staining was done with primary mouse anti-human monoclonal antibodies specific for CD31 (DaKoCytomation, Glostrup, Denmark), and RANKL (Clone 2C3A 12 C, BioVendor GmbH, Heidelberg, Germany).

    Techniques: Expressing, Activity Assay